Home/Pipeline/Quizartinib (via Daiichi Sankyo)

Quizartinib (via Daiichi Sankyo)

Oncology (specific type not detailed)

CommercialActive

Key Facts

Indication
Oncology (specific type not detailed)
Phase
Commercial
Status
Active
Company

About GENESIS Pharma

GENESIS Pharma is a leading regional commercial partner in Central and Eastern Europe, dedicated to bringing innovative biopharmaceuticals and orphan drugs to patients. With nearly three decades of experience, the company has built a strong network of subsidiaries across the CEE region and strategic alliances with global biopharma innovators. Its business model centers on in-licensing and commercializing advanced therapies for chronic and rare diseases, making it a critical access channel for groundbreaking treatments in its markets.

View full company profile